| (Values in U.S. Thousands) | Dec, 2018 | Dec, 2017 | Apr, 2026 | Apr, 2026 | Apr, 2026 |
| Sales | 35,220 | 15,960 | 0 | 0 | 0 |
| Sales Growth | +120.68% | unch | unch | unch | unch |
| Net Income | -10,460 | 5,310 | 0 | 0 | 0 |
| Net Income Growth | -296.99% | unch | unch | unch | unch |
Canntrust Holdings Inc (CTST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
CannTrust Holdings Inc. operates as a pharmaceutical company. It develops and produces medical cannabis for health care sectors. CannTrust Holdings Inc. is based in Vaughan, Canada.